Works matching IS 00099236 AND DT 2018 AND VI 104 AND IP 4
Results: 24
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 597, doi. 10.1002/cpt.1206
- Publication type:
- Article
In This Issue.
- Published in:
- 2018
- Publication type:
- Abstract
Highlights.
- Published in:
- 2018
- Publication type:
- Abstract
Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 619, doi. 10.1002/cpt.1192
- By:
- Publication type:
- Article
Risk of Bias and Quality of Evidence for Treatment of ADHD With Stimulant Medication.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 638, doi. 10.1002/cpt.1186
- By:
- Publication type:
- Article
Treating a Child With Mental Illness.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 592, doi. 10.1002/cpt.1182
- By:
- Publication type:
- Article
The Way Forward for Mechanism‐Based Therapeutics in Genetically Defined Neurodevelopmental Disorders.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 603, doi. 10.1002/cpt.1181
- By:
- Publication type:
- Article
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention‐Deficit/Hyperactivity Disorder.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 606, doi. 10.1002/cpt.1149
- By:
- Publication type:
- Article
Understanding Hematological Toxicities Using Mathematical Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 644, doi. 10.1002/cpt.1080
- By:
- Publication type:
- Article
Response to: “Enlisting Emergency Medicine Clinicians to Help Reduce Strokes in High‐Risk Patients With Atrial Fibrillation and Flutter”.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 615, doi. 10.1002/cpt.1143
- By:
- Publication type:
- Article
Getting to Long‐Term Effectiveness and Safety of Attention‐deficit Hyperactivity Disorder Medications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 610, doi. 10.1002/cpt.1137
- By:
- Publication type:
- Article
In‐utero Selective Serotonin Reuptake Inhibitor Antidepressant Exposure: Fetal Programing and Developmental Interactions With Context.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 616, doi. 10.1002/cpt.1134
- By:
- Publication type:
- Article
A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 655, doi. 10.1002/cpt.1111
- By:
- Publication type:
- Article
Enlisting Emergency Medicine Clinicians to Help Reduce Strokes in High‐Risk Patients With Atrial Fibrillation and Flutter.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 613, doi. 10.1002/cpt.1144
- By:
- Publication type:
- Article
Gene‐Specific Variant Classifier (DPYD‐Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 709, doi. 10.1002/cpt.1020
- By:
- Publication type:
- Article
Endogenous Metabolites‐Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 687, doi. 10.1002/cpt.1008
- By:
- Publication type:
- Article
Potent Anti‐Inflammatory and Pro‐Resolving Effects of Anabasum in a Human Model of Self‐Resolving Acute Inflammation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 675, doi. 10.1002/cpt.980
- By:
- Publication type:
- Article
Development and Qualification of a Drug‐Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 699, doi. 10.1002/cpt.998
- By:
- Publication type:
- Article
Transporter‐Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 749, doi. 10.1002/cpt.997
- By:
- Publication type:
- Article
Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 733, doi. 10.1002/cpt.987
- By:
- Publication type:
- Article
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 664, doi. 10.1002/cpt.1006
- By:
- Publication type:
- Article
Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population‐Based Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 719, doi. 10.1002/cpt.954
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 585, doi. 10.1002/cpt.848
- Publication type:
- Article
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 742, doi. 10.1002/cpt.991
- By:
- Publication type:
- Article